Mark Patrick Farrell

Title: Mark Patrick Farrell: Innovator in Medical Research

Introduction

Mark Patrick Farrell is a notable inventor based in Lawrence, KS (US). He has made significant contributions to the field of medical research, particularly in the development of innovative therapeutic compounds. With a total of 2 patents, his work focuses on enhancing the efficacy of treatments for various medical conditions.

Latest Patents

Farrell's latest patents include groundbreaking technologies. One of his patents is titled "Conjugates with inhibitory receptor ligands to induce anergy in insulin-binding B cells." This patent provides conjugates, methods of making the same, and their uses, which are instrumental in inducing anergy in insulin-binding B cells. Another significant patent is for "Kifunensine derivatives," which relates to compounds that enhance the activity of anti-CD20 monoclonal antibodies. This technology is crucial for sensitizing cell lines that are resistant to these antibodies.

Career Highlights

Mark Patrick Farrell is affiliated with the University of Kansas Medical Center Research Institute. His work at this esteemed institution has allowed him to explore innovative solutions in medical research. His contributions have the potential to impact the treatment of various diseases significantly.

Collaborations

Farrell has collaborated with notable colleagues, including Suresh Eknath Kurhade and Patrick Andrew Ross. These collaborations have fostered a productive research environment, leading to advancements in their respective fields.

Conclusion

Mark Patrick Farrell is a distinguished inventor whose work in medical research is paving the way for innovative treatments. His patents reflect a commitment to improving healthcare through scientific discovery.